This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

New Israeli Client Selects DATATRAK ONE™ For Oncology Program

CLEVELAND, April 23, 2013 /PRNewswire/ --  D ATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced an Israeli biopharmaceutical company chose to standardize on the D ATATRAK ONE™ clinical research platform for its oncology program. Understanding the benefit of the unified platform, they will utilize multiple products and modules within the software suite – uEDC, including medical coding and uIRT, including both Randomization and Clinical Supplies Management – to reduce the cost of their clinical trials.

(Logo: http://photos.prnewswire.com/prnh/20130107/CL38347LOGO)

"Our new client has an exciting history of developing novel immunotherapy drug products," stated Laurence P. Birch, D ATATRAK's Chairman of the Board and CEO. "Pairing our expansive technology with their innovative approach to drug development, we are able to reduce costs across their oncology drug program as well as accelerate their clinical trial timelines."

D ATATRAK ONE™:The D ATATRAK ONE™ Clinical Research Platform is an easy to use, cloud-based clinical enterprise solution that empowers Sponsors and CROs to efficiently design, deliver and manage clinical trials.  From strategy and planning to resource management and study execution needs, clients manage their entire product portfolio in a single system with one username and password.  D ATATRAK's unified clinical enterprise solution consists of seven products: uCTMS, uDesign, uEDC, uIRT, uSafety, uTrain and uCDR.

Join D ATATRAK Thought Leaders:

About D ATATRAK International, Inc. D ATATRAK International is a worldwide technology and services company delivering unified eClinical™ solutions and related services for the clinical trials industry. D ATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via D ATATRAK's Clinical and Consulting Services™ group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The D ATATRAK ONE™ software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I – Phase IV drug and device studies in multiple languages throughout the world. D ATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit  http://www.datatrak.net.

All contracts are subject to possible delays or cancellation or can change in scope in a positive or negative direction. Therefore, current backlog is not necessarily indicative of the Company's future quarterly or annual revenue. Historically, backlog has been a poor predictor of the Company's short-term revenue.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,973.23 -97.17 -0.54%
S&P 500 2,101.18 -13.31 -0.63%
NASDAQ 4,959.9580 -56.9710 -1.14%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs